These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17134916)

  • 1. Cardiorespiratory fitness: A predictor of cortical plasticity in multiple sclerosis.
    Prakash RS; Snook EM; Erickson KI; Colcombe SJ; Voss MW; Motl RW; Kramer AF
    Neuroimage; 2007 Feb; 34(3):1238-44. PubMed ID: 17134916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct mechanisms of altered brain activation in patients with multiple sclerosis.
    Morgen K; Sammer G; Courtney SM; Wolters T; Melchior H; Blecker CR; Oschmann P; Kaps M; Vaitl D
    Neuroimage; 2007 Sep; 37(3):937-46. PubMed ID: 17627848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in cerebral activation patterns in idiopathic inflammatory demyelination using the paced visual serial addition task: an fMRI study.
    Rachbauer D; Kronbichler M; Ropele S; Enzinger C; Fazekas F
    J Neurol Sci; 2006 May; 244(1-2):11-6. PubMed ID: 16480742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
    Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. fMRI investigation of disinhibition in cognitively impaired patients with multiple sclerosis.
    Smith AM; Walker LA; Freedman MS; DeMeulemeester C; Hogan MJ; Cameron I
    J Neurol Sci; 2009 Jun; 281(1-2):58-63. PubMed ID: 19344919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paced visual serial addition test in multiple sclerosis.
    Nagels G; Geentjens L; Kos D; Vleugels L; D'hooghe MB; Van Asch P; Vuylsteke K; De Deyn PP
    Clin Neurol Neurosurg; 2005 Apr; 107(3):218-22. PubMed ID: 15823678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the neural correlates underlying action observation in multiple sclerosis patients.
    Pierno AC; Turella L; Grossi P; Tubaldi F; Calabrese M; Perini P; Barachino L; Morra A; Gallo P; Castiello U
    Exp Neurol; 2009 Jun; 217(2):252-7. PubMed ID: 19285072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of attention related structures in multiple sclerosis patients.
    Nebel K; Wiese H; Seyfarth J; Gizewski ER; Stude P; Diener HC; Limmroth V
    Brain Res; 2007 Jun; 1151():150-60. PubMed ID: 17397807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional MRI in multiple sclerosis.
    Rocca MA; Filippi M
    J Neuroimaging; 2007 Apr; 17 Suppl 1():36S-41S. PubMed ID: 17425733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalamic atrophy and cognition in multiple sclerosis.
    Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
    Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy-induced plasticity of cognitive functions in MS patients: insights from fMRI.
    Penner IK; Kappos L; Rausch M; Opwis K; Radü EW
    J Physiol Paris; 2006 Jun; 99(4-6):455-62. PubMed ID: 16713204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical recruitment during selective attention in multiple sclerosis: an fMRI investigation of individual differences.
    Prakash RS; Erickson KI; Snook EM; Colcombe SJ; Motl RW; Kramer AF
    Neuropsychologia; 2008 Oct; 46(12):2888-95. PubMed ID: 18577390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "mirror-neuron system" in MS: A 3 tesla fMRI study.
    Rocca MA; Tortorella P; Ceccarelli A; Falini A; Tango D; Scotti G; Comi G; Filippi M
    Neurology; 2008 Jan; 70(4):255-62. PubMed ID: 18077798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural connectivity influences brain activation during PVSAT in Multiple Sclerosis.
    Bonzano L; Pardini M; Mancardi GL; Pizzorno M; Roccatagliata L
    Neuroimage; 2009 Jan; 44(1):9-15. PubMed ID: 18790063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transverse diffusivity of cerebral parenchyma predicts visual tracking performance in relapsing-remitting multiple sclerosis.
    Warlop NP; Achten E; Fieremans E; Debruyne J; Vingerhoets G
    Brain Cogn; 2009 Dec; 71(3):410-5. PubMed ID: 19576672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis.
    Ranjeva JP; Audoin B; Au Duong MV; Confort-Gouny S; Malikova I; Viout P; Soulier E; Pelletier J; Cozzone PJ
    J Neurol Sci; 2006 Jun; 245(1-2):161-7. PubMed ID: 16631206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.